We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$8.59B
AUM Growth
+$1.04B
Cap. Flow
+$618M
Cap. Flow %
7.2%
Top 10 Hldgs %
17.54%
Holding
2,356
New
64
Increased
649
Reduced
1,253
Closed
386

Top Sells

Rank Stock Value
1
BMS
Bemis
BMS
+$5.05M
2
SWKS icon
Skyworks Solutions
SWKS
+$4.16M
3
HBI
Hanesbrands
HBI
+$3.87M
4
AAP icon
Advance Auto Parts
AAP
+$3.77M
5
SLG icon
SL Green Realty
SLG
+$3.51M

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Healthcare 15.92%
3 Financials 15.89%
4 Communication Services 8.09%
5 Industrials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUSA icon
826
Murphy USA
MUSA
$11.3B
$1.06M 0.01%
15,410
-14,785
-49% -$878K
RGLD icon
827
Royal Gold
RGLD
$17.1B
$1.06M 0.01%
16,904
-22,986
-58% -$1.51M
MAN icon
828
ManpowerGroup
MAN
$2.39B
$1.06M 0.01%
15,539
-27,970
-64% -$1.86M
CAVM
829
DELISTED
Cavium, Inc.
CAVM
$1.06M 0.01%
17,138
-9,764
-36% -$517K
FULT icon
830
Fulton Financial
FULT
$4.7B
$1.05M 0.01%
84,660
-64,940
-43% -$765K
CY
831
DELISTED
Cypress Semiconductor
CY
$1.04M 0.01%
72,961
-79,919
-52% -$883K
IEX icon
832
IDEX
IEX
$16.5B
$1.04M 0.01%
13,310
-28,374
-68% -$2.11M
GBCI icon
833
Glacier Bancorp
GBCI
$6.55B
$1.03M 0.01%
37,248
-12,960
-26% -$351K
MACK
834
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.03M 0.01%
11,589
-214
-2% -$15.6K
TTPH
835
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.03M 0.01%
+1,295
New +$697K
PRE
836
DELISTED
PARTNERRE LTD
PRE
$1.03M 0.01%
8,997
+187
+2% +$21.3K
ADT
837
DELISTED
ADT Corp
ADT
$1.02M 0.01%
28,286
+2,318
+9% +$79.7K
BEAV
838
DELISTED
B/E Aerospace Inc
BEAV
$1.02M 0.01%
17,657
-58,087
-77% -$3.24M
WOLF icon
839
Wolfspeed
WOLF
$1.2B
$1.02M 0.01%
31,746
-42,684
-57% -$1.4M
TIME
840
DELISTED
Time Inc.
TIME
$1.02M 0.01%
41,431
-57,997
-58% -$1.31M
AYI icon
841
Acuity Brands
AYI
$9.88B
$1.02M 0.01%
7,272
-15,239
-68% -$2.07M
HALO icon
842
Halozyme
HALO
$9.72B
$1.02M 0.01%
105,242
-395
-0.4% -$3.51K
CMC icon
843
Commercial Metals
CMC
$7.63B
$1.01M 0.01%
62,299
-62,691
-50% -$1.01M
TRMK icon
844
Trustmark
TRMK
$2.73B
$1.01M 0.01%
41,347
-35,484
-46% -$846K
SSNC icon
845
SS&C Technologies
SSNC
$17.8B
$1.01M 0.01%
34,660
-24,240
-41% -$601K
SIRO
846
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$1.01M 0.01%
11,611
-18,389
-61% -$1.52M
WWAV
847
DELISTED
The WhiteWave Foods Company
WWAV
$1.01M 0.01%
28,983
-61,705
-68% -$2.19M
ACM icon
848
Aecom
ACM
$9.07B
$1.01M 0.01%
33,192
-22,945
-41% -$716K
INGR icon
849
Ingredion
INGR
$6.38B
$1.01M 0.01%
11,885
-26,735
-69% -$2.13M
CPHD
850
DELISTED
Cepheid Inc
CPHD
$1.01M 0.01%
18,581
-11,360
-38% -$574K

Similar funds

ProShare Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, ProShare Advisors held 2,356 positions worth $8.59B, up 14% from $7.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

ProShare Advisors deployed $618M of net new capital in Q4 2014, opening 64 new positions and adding to 649 existing holdings. Its largest new stake was Liberty Global Class C: 287,742 shares worth $11.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Bemis, an estimated $5.05M trimmed.

  • ProShare Advisors's largest Q4 2014 buy was Liberty Global Class C: 287,742 shares worth $11.2M.
  • ProShare Advisors added most to Apple in Q4 2014, an estimated $68.6M increase.
  • ProShare Advisors's biggest Q4 2014 reduction was Bemis, cutting an estimated $5.05M.
  • ProShare Advisors fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $3.32M.
  • ProShare Advisors's ten largest holdings make up 18% of its $8.59B portfolio in Q4 2014.
  • ProShare Advisors opened 64 new positions and closed 386 in Q4 2014.
  • ProShare Advisors's portfolio value rose 14% quarter-over-quarter to $8.59B.

Based on ProShare Advisors's 13F filing for Q4 2014, filed 30 Jan 2015.